Top Growth Trends in the Anti-Asthmatics And COPD Drugs Market: Insights into Market Size and Opportunities for 2025-2034
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What External and Internal Drivers Are Contributing to the Growth of theAnti-Asthmatics And COPD Drugs Market?
The anti-asthmatics and COPD drugs market is driven by modifiable risk factors such as smoking, insufficient physical activity, and poor dietary choices. While there is a global decrease in smoking, countries like China, India, Indonesia, and Nigeria are experiencing an escalating incidence of smoking. For example, by 2025, tobacco smokers are projected to rise by 24 million in Indonesia and 7 million in Nigeria, with over 40% of worldwide cigarette usage being focused in China. Consumption of fats, including saturated fatty acids – a risk component for Asthma and COPD – is more prevalent in affluent nations like the USA and Europe. As per WHO, in developed countries, fats contribute to over 35% of total energy requirements, as opposed to less than 20% in impoverished countries, and under 25% in lower-middle-income nations.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3802&type=smp
What is the Predicted Annual Growth Rate of theAnti-Asthmatics And COPD Drugs Market Impact Industry Trends by 2034?
In recent times, there has been robust growth in the market size of anti-asthmatics and COPD drugs. The market is projected to expand from $80.82 billion in 2024 to $86.11 billion in 2025, delivering a compound annual growth rate (CAGR) of 6.6%. Factors contributing to the growth experienced in the historical period include an uptick in respiratory illnesses, a rise in tobacco smoking, global warming, an ageing population, emerging markets, innovations in drug discovery, and increased spending on healthcare.
Anticipated to witness substantial expansion in the coming years, the market for anti-asthmatics and chronic obstructive pulmonary disease (COPD) medicines is projected to escalate to $107.01 billion by 2029, with a compound annual growth rate (CAGR) of 5.6%. This anticipated acceleration in the forecast period is credited to several factors: the growing prevalence of e-cigarettes/vaping, the increase in obesity rates, advancements in technology, a significant population yet to be diagnosed, the administration of anti-asthmatics and COPD medicines for COVID-19 treatment, and an increased intake of fatty foods. During the forecast period, key trends might include creating asthma-focused probiotic drugs, developing anti-IL-5 medications for business portfolio diversification, launching innovative products to maintain and reinforce market positions amidst intense competition, boosting investments in bioelectric medicine developments, enhancing collaboration efforts, offering personalized treatments, crafting combination drugs for superior outcomes, and harnessing biotechnology for the increasing demand of biologics.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3802
Which Upcoming Market Trends and Innovations Are Set to Influence theAnti-Asthmatics And COPD Drugs Market’s Path Forward?
Prominent businesses in the anti-asthmatics and COPD drugs sector are pioneering new product lines such as fixed-dose combination (FDC) drugs that includes Indacaterol and Mometasone to improve their market profitability. The once-daily Indacaterol and Mometasone FDC drug, administered via a Breezhaler device, is specially made for the consistent management of asthma symptoms in patients. For example, in June 2022, the US-based Glenmark Pharmaceuticals introduced a uniquely combined fixed-dose (FDC) drug, branded as Indamet, designed for those struggling with unmanageable asthma in India. This medication is presented in three different forms, each containing a consistent 150 mcg dose of Indacaterol and varying doses of Mometasone, available at strengths of 80 mcg, 160 mcg, and 320 mcg.
Who Are the Dominant Market Players Pushing the Boundaries of theAnti-Asthmatics And COPD Drugs Market?
Major companies operating in the anti-asthmatics and COPD drugs market include GlaxoSmithKline plc, AstraZeneca plc, Boehringer Ingelheim GmbH, F. Hoffmann-La Roche Ltd., Novartis AG, Sanofi S.A., Chiesi Farmaceutici S.p.A., Teva Pharmaceutical Industries Limited, Merck & Co. Inc., Sumitomo Dainippon Pharma Co. Ltd., China National Pharmaceutical Group Co. Ltd. (Sinopharm), Shanghai Acebright Pharmaceuticals Group Co. Ltd., Jiangsu Hengrui Medicine Co. Ltd, Hanmi Pharmaceutical, Cipla Limited, Aurobindo Pharma Limited, KYORIN Holdings Inc., Nichi-Iko Pharmaceutical Co. Ltd., Otsuka Pharmaceutical Co. Ltd., Daewoong Pharmaceutical Co. Ltd, Shanghai Anovent Pharma, China Meheco Group Co. Ltd., Lupin Limited, ASGEN Pharmaceutical Co. Ltd, Abbott Laboratories, Pfizer, Vectura Group, Bristol Myers Squibb, Apotex Inc., EMS Pharma, Hypermarcas, Ache, Eurofarma, Bayer, Biolab Farmaceuticad, Cristalia, Libbs, Julphar, Neopharma, Adcock Ingram, Aspen Nigeria
Order Your Report Now For A Swift Delivery:
What Are the Core Segments of the Anti-Asthmatics And COPD Drugs Market, and How Do They Contribute to Growth?
The anti-asthmatics and COPD drugs market covered in this report is segmented –
1) By Drug Class: Bronchodilators, Anti-Inflammatory Drugs, Monoclonal Antibodies, Combination Drugs
2) By Distribution Channel: Hospital Pharmacies, General Pharmacies, Online Retailers
3) By End User: Asthma Patients, COPD Patients
4) By Therapy: Preventive, Curative
5) By Route Of Administration: Oral, Inhaled, Intravenous, Subcutaneous
6) By Age Group: Below 5, 5-14, 15-60, Above 60
Subsegments:
1) By Bronchodilators: Short-Acting Beta-Agonists (SABAs), Long-Acting Beta-Agonists (LABAs), Anticholinergics (Short-Acting And Long-Acting), Methylxanthines
2) By Anti-Inflammatory Drugs: Corticosteroids (Inhaled And Systemic), Leukotriene Modifiers, Phosphodiesterase-4 Inhibitors
3) By Monoclonal Antibodies: Anti-IgE Antibodies, Anti-IL-5 Antibodies, Anti-IL-4 Or IL-13 Antibodies
4) By Combination Drugs: Combination Bronchodilator Inhalers (LABA + LAMA), Inhaled Corticosteroid + Long-Acting Beta-Agonist (ICS + LABA)
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=3802&type=smp
What Regions Are Dominating the Anti-Asthmatics And COPD Drugs Market Growth?
North America was the largest region in the anti-asthmatics and COPD drugs market in 2024. Middle East is expected to be the fastest-growing region in the global anti-asthmatics and COPD drugs market during the forecast period. The regions covered in the anti-asthmatics and COPD drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Reports Similar to the Global Anti-Asthmatics And COPD Drugs Market 2025, By The Business Research Company:
Anti-Viral Drug Therapy Global Market Opportunities And Strategies To 2030: COVID-19 Implications And Growth
https://www.thebusinessresearchcompany.com/report/anti-viral-drug-therapy-market
COVID-19 Drug Associated APIs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/covid19-drug-associated-api-global-market-report
Hospital Acquired Infections Testing Kits Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
